Nasal administration of a cognition enhancer provides improved bioavailability but not enhanced brain delivery
- 1 September 1990
- journal article
- research article
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 79 (9) , 771-772
- https://doi.org/10.1002/jps.2600790904
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- Nasal systemic drug delivery: Y.W. Chien, K.S.E. Su and S.F. Chang, Marcel Dekker, New York, NY, 1989, 310 pages, $99.75Journal of Controlled Release, 1990
- EEG brain mapping in evaluating the time‐course of the central action of DUP 996‐a new acetylcholine releasing drug.British Journal of Clinical Pharmacology, 1989
- UPTAKE OF ALUMINIUM INTO CENTRAL NERVOUS SYSTEM ALONG NASAL-OLFACTORY PATHWAYSThe Lancet, 1987
- β‐Endorphin: intranasal administration increases the serum prolactin level in monkeyInternational Journal of Peptide and Protein Research, 1986
- Avenues for entry of peripherally administered protein to the central nervous system in mouse, rat, and squirrel monkeyJournal of Comparative Neurology, 1986
- Pharmacokinetics of progesterone after its administration to ovariectomized rhesus monkeys by injection, infusion, or nasal spraying.Proceedings of the National Academy of Sciences, 1982